Follow us on Twitter: @CanadianGastric
Logo Logo Logo Logo Logo
  • Home
  • Patients
    • Past research
      • View highlights of significant research in the field of gastric cancer
    • Ongoing trials
      • British Columbia
      • Alberta
      • Manitoba
      • Saskatchewan
      • Ontario
      • Quebec
      • Maritimes
    • Informational resources
      • Glossary
      • Non-Curative Treatments
      • Nutrition
      • Gastrectomy
  • Providers
    • Become a Member
    • Membership Directory
    • Newsletter Archive
  • Support the CaGCA
  • Home
  • Patients
    • Past research
      • View highlights of significant research in the field of gastric cancer
    • Ongoing trials
      • British Columbia
      • Alberta
      • Manitoba
      • Saskatchewan
      • Ontario
      • Quebec
      • Maritimes
    • Informational resources
      • Glossary
      • Non-Curative Treatments
      • Nutrition
      • Gastrectomy
  • Providers
    • Become a Member
    • Membership Directory
    • Newsletter Archive
  • Support the CaGCA
Search:
 

Glossary

Home » Patients  » Informational resources » Glossary
  • “-ectomy”
  • “gastr-”
  • Adverse effects
  • Angiogenesis
  • Benign
  • Cancer
  • CDH1 mutation
  • Cell
  • Chemoradiotherapy
  • Clinical practice guidelines
  • Compliance
  • Control group
  • Cytoreductive Surgery (CRS)
  • Disease-free survival
  • Distal
  • Distal Gastrectomy
  • Drug Trial Phases
  • Esophagocardiac resection
  • First line therapy
  • Gastrectomy
  • Gastroesophageal junction
  • Gastrointestinal (GI) tract
  • Genetic mutation
  • HER-2
  • High-risk
  • Hyperthermic Intraperitoneal Chemotherapy (HIPEC)
  • Impact Factor
  • Intention to treat (ITT)
  • Intraoperative Frozen Resection
  • Laparoscopic surgery
  • Long-term outcomes
  • Lymph Nodes
  • Lymphadenectomy
  • Malignant
  • Median survival
  • Metastasectomy
  • Metastasis
  • Minimally invasive
  • Neoadjuvant Intraperitoneal Systemic chemotherapy (NIPS)
  • Overall survival
  • Performance status
  • Perioperative
  • Peritoneum
  • Post-operative complications
  • Postoperative
  • Preoperative
  • Primary research
  • Primary Site
  • Prophylactic gastrectomy
  • Proximal
  • Proximal Gastrectomy
  • Quality of life
  • R-0 Margins
  • Radiation therapy
  • Randomized
  • Randomized Controlled Trial
  • Reattachment
  • Relapse
  • Resectable gastric cancer
  • Screening
  • Second line therapy
  • Secondary research
  • Secondary site
  • Short-term outcomes
  • Standard of care
  • Surveillance
  • Systematic review
  • TNM System
  • Total gastrectomy
 
Share this page
Share on Facebook
Facebook
Tweet about this on Twitter
Twitter
Share on LinkedIn
Linkedin

Disclaimer    |    Email us    |    Follow us    |    DONATE

Copyright 2021 Canadian Gastric Cancer Association